The Defense Logistics Agency - Troop Support is soliciting proposals for the supply of Intranasal Influenza Vaccine for the 2019-2020 flu season.  A one-year indefinite quantity contract is solicited.    Approximately 150,000 doses for the annual period are included in this requirement.  (Quantities may increase or decrease pending receipt of final Service requirements.)

The vaccine shall be shall be a live, attenuated, intranasal, quadrivalent vaccine, licensed by the FDA, intended for active immunization for the prevention of influenza. The vaccine shall meet the minimum formula for the influenza vaccine as determined by the FDA's Vaccines and Related Biological Products Advisory Committee.  The vaccine shall be a pre-measured 0.2 ML dose, each dose shall be pre-filled in a commercially available nasal syringe unit suitable for nasal administration in healthy individuals aged 2 years through 49 years.

Other specification data included in the solicitation.  Successful contractor must have FDA approval and the vaccine must be recommended by the ACIP. National Stock Numbers shall be established at time of award.

An indefinite quantity type contract is proposed.  The quantity indicated is an annual estimate only. The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate.

The vaccine shall be delivered directly to military treatment facilities and DoD activities worldwide. The contractor shall be capable of delivering 50% of the requirement by October 25, 2019 and the residual 50% by November 15, 2019.  This delivery schedule is the preferred delivery schedule.  Other delivery schedules will be considered.  

Bid Protests Not Available